Prof Dean Ho found that when antiviral drugs molnupiravir and Paxlovid were each combined with the protease-inhibiting drug YH-53, the mix was effective against the Omicron variant of the coronavirus in lab settings. He used his AI platform, known as IDentif.AI, to determine the combination and dosage.

Read more: https://www.straitstimes.com/singapore/nus-scientists-leverage-ai-platform-to-improve-effectiveness-of-covid-19-drugs-against-omicron